In Q2 2026 (Apr–Jun), order intake rose to SEK 568.1M from SEK 501.3M and net sales increased to SEK 486.4M from SEK 448.7M. Gross profit surged to SEK 136.5M from SEK 85.3M, lifting gross margin to 28.1% (from 19.0%). Operating profit (EBIT) turned positive at SEK 25.5M versus SEK -20.3M prior year, and adjusted EBIT improved to SEK 34.5M from SEK 12.4M, translating to an adjusted operating margin of 7.1% (from -2.8%).
The real signal is not the top-line growth; it is the step-change in gross margin. That usually means either pricing discipline is finally sticking, a higher-margin product mix is taking share, or the plant is running with enough volume to absorb fixed costs. In all three cases, the equity can re-rate quickly because incremental revenue now drops through at a much higher rate than last quarter.
The second-order effect is on backlog quality and working capital. Order intake above sales suggests the company is building future revenue, but if that comes from short-cycle orders or low-margin fill-in business, the margin improvement can fade just as fast. What matters over the next 1-2 quarters is whether EBIT turns from a margin artifact into a cash-flow story: stable receivables, controlled inventory, and no spike in capital intensity.
Competitively, this puts pressure on peers that are still trying to defend share with discounting. If this improvement is sustainable, suppliers may see steadier pull-through while customers lose bargaining power; if it is not, then this was likely a one-off rebound in mix rather than a durable moat. The contrarian view is that the market may over-interpret one strong quarter as a full turnaround; the falsifier is any rollback in gross margin back toward the high-teens/low-20s or a deceleration in order intake next quarter.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.25